Cargando…
AG490 protects cerebral ischemia/reperfusion injury via inhibiting the JAK2/3 signaling pathway
BACKGROUND: Cerebral ischemia/reperfusion injury is a severe problem in patients with brain ischemia. Brain injury caused by the immune response is important in the pathogenesis of cerebral ischemia/reperfusion injury and immune pathways. It is important to investigate potential targets for the trea...
Autores principales: | Fan, Lichao, Zhou, Lichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821583/ https://www.ncbi.nlm.nih.gov/pubmed/33098244 http://dx.doi.org/10.1002/brb3.1911 |
Ejemplares similares
-
Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway
por: Hu, Guang-qiang, et al.
Publicado: (2017) -
AG490 ameliorates early brain injury via inhibition of JAK2/STAT3-mediated regulation of HMGB1 in subarachnoid hemorrhage
por: An, Ji-Yang, et al.
Publicado: (2018) -
The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro
por: Zhou, Ying, et al.
Publicado: (2020) -
Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway
por: Ji, Hui, et al.
Publicado: (2022) -
Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion
injury by inhibiting neuroinflammation through the JAK2/STAT3
pathway
por: Liu, Huan, et al.
Publicado: (2022)